In Treatment of Insomnia Insomnia is a common sleep disorder in which there is difficulty in falling or staying asleep at night. Zolpid 6.25mg Tablet ER helps treat insomnia as well as improves sleep quality. Zolpid 6.25mg Tablet ER works by slowing activity in the brain to allow sleep. This helps you relax and feel more energetic. It also helps you concentrate better and improves your quality of life. With Zolpid 6.25mg Tablet ER, your sleep problems should improve within 7 to 10 days. Apart from this, it is advisable to make some lifestyle changes to sleep better.
Zolpid 6.25mg Tablet ER may cause excessive drowsiness with alcohol.
Zolpid 6.25mg Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Zolpid 6.25mg Tablet ER is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Zolpid 6.25mg Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Zolpid 6.25mg Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Zolpid 6.25mg Tablet ER is recommended. However, inform your doctor if you have any kidney disease.
Zolpid 6.25mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Zolpid 6.25mg Tablet ER may be needed. Please consult your doctor. Zolpid 6.25mg Tablet ER is generally started at a low dose in patients with mild to moderate liver disease and is not recommended in patients with severe liver disease.
If you miss a dose of Zolpid 6.25mg Tablet ER, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Ipca Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanofi India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sansu Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Icon Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Consern Pharma Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ryon Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)